Last reviewed · How we verify

NCT04218331: BLOOM

Boosting Language Outcomes of Minimally Verbal Children With ASD (BLOOM)

Active, enrolled NA Last updated 28 January 2026
What this trial tests

NA trial testing JASPER in Autism Spectrum Disorder in 56 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
29 April 2021
Primary endpoint
15 April 2026
31 August 2026

Quick facts

Lead sponsorUniversity of California, Los Angeles
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment56
Start date29 April 2021
Primary completion15 April 2026
Estimated completion31 August 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Los Angeles

Who can join

Adults 42 Months to 66 Months, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this project, the investigator will test the effect of augmenting an evidence based joint attention intervention (JASPER) with a motor-sound system intervention (PROMPT) compared to JASPER only on speech and language outcomes. The investigator will model change over a year to determine the percentage of children who cross the hurdle from single words to word combinations by Kindergarten. The proposed research will foster the understanding of the mechanisms underlying speech heterogeneity in ASD, thereby ultimately contributing to the development of more personalized, efficacious interventions. Upon qualification to the study (after entry assessments), the child will be randomized to receive JASPER alone (play-based intervention) or JASPER plus PROMPT (both play-based and speech-based interventions). The active intervention will last for 12 weeks, 60 minute sessions twice a week. There are assessments scheduled at entry (6.5 hours), end of study (exit-2.5 hours), 3 month follow up (2 hours), and when the child turns 6 years of age (2 hours). The total time commitment per participant is 37 hours.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Overcoming hurdles to intervention studies with autistic children with profound communication difficulties and their families.
    McKinney A, Weisblatt EJ, Hotson KL, Bilal Ahmed Z, et al · · 2021 · cited 16× · PMID 33827289 · DOI 10.1177/1362361321998916

Verify or expand the search:

Other trials of JASPER

Trials testing the same drug.

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other University of California, Los Angeles trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04218331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing